Artelon, founded in 2013, is a pioneering company in the field of Biotechnology and Medical Devices, with a niche focus on dynamic ankle stabilization. Headquartered in the United States, the company is carving a niche in Health Care and Manufacturing through its innovative use of bio-textiles.
Artelon's technology is at the forefront of tendon and ligament reconstruction. By employing specially designed bio-textiles, the company offers solutions that not only reinforce soft tissue repair but also maintain native motion and enhance regeneration. This innovative approach promises to accelerate recovery, allowing patients to regain strength and stability more efficiently.
The company recently secured a $20.00M Series B investment on 24 May 2023, with the participation of Vensana Capital. This funding underlines investor confidence in Artelon's potential to transform orthopedic care and solidify its position as a market leader in dynamic augmentation technologies.